Biotech News
-
Hemostemix Announces Warrant Repricing and Extension
May 6, 2021 (Source) — Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) (“Hemostemix” or the “Company”) is…
-
Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of Product Licenses for MultiXThin Radiographic Barium Contrast
May 5, 2021 (Source) — Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (the “Company” or “Voyageur”) is pleased to announce that it…
-
Red Light Holland Receives Patent Pending Status For ‘Find Your Dose’ Customization of Microdosing Kits Based on Biometric and Movement Data
May 5, 2021 (Source) — Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light…
-
StageZero Life Sciences to Offer COVID-19 Saliva Test Kits Throughout Canada
May 5, 2021 (Source) — StageZero Life Sciences, Ltd. (TSX:SZLS) (“StageZero” or the “Company”), a specialist in PCR testing…
-
Rritual Superfoods Chief Innovation Officer Establishes Innovation Division
May 5, 2021 (Source) — Recently Appointed, Stacey Gillespie, Advances R&D Practices and Fuels Rritual’s Functional Superfoods Product Pipeline for National Rollout Rritual Superfoods Inc.…
-
Perimeter Medical Imaging AI Reports 2020 Financial Results and Provides Corporate Update
April 30, 2021 (Source) — Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology…
-
Hemostemix Provides a Clinical Trial Update and Announces the Release and Filing of 2020 Year-end Audited Financial Statements and Management Discussion and Analysis
April 30, 2021 (Source) — Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased…
-
Valeo Pharma Announces Voting Results of its 2021 Annual General and Special Meeting of Shareholders
April 29, 2021 (Source) — Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”), a…
-
Rritual Superfoods Third Full Scale Manufacturing Run is Scaled to Meet Growing Retail Demand
April 29, 2021 (Source) — Production Designed to Serve Recently Announced CROSSMARK Driven Rollout Rritual Superfoods Inc. (“Rritual” or the “Company”) (CSE:…
-
Valeo Pharma’s Redesca® and Redesca HP® to Be Covered Under the Ontario Public Drug Benefit Program
April 28, 2021 (Source) — Ontario represents 37% of the Canadian low molecular weight heparin market Additional provincial coverage…
